EUVIMEDEUVIMED entdecken
Leitlinie

Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group

Sudhakar K Venkatesh, Christopher L Welle, Frank H Miller, Kartik Jhaveri, Kristina I Ringe, John E Eaton, Helen Bungay, Lionel Arrivé, Ahmed Ba-Ssalamah, Aristeidis Grigoriadis, Christoph Schramm, Ann S Fulcher und 1 weitere

European Radiology · 2022-02 · 32 (2) · 923-937

DOI: 10.1007/s00330-021-08147-7 ↗

Kurz gefasst

Leitlinie in der Zeitschrift European Radiology, online erschienen am 06.08.2021. Verfasst von Sudhakar K Venkatesh und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Abdominal Imaging, Department of Radiology, Mayo Clinic, 200, First Street SW, Rochester, MN, 55905, USA. Venkatesh.sudhakar@mayo.edu. Hauptthemen laut MEDLINE: Bile Duct Neoplasms, Cholangiocarcinoma, Cholangitis, Sclerosing. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary sclerosing cholangitis (PSC) is a chronic inflammatory disorder affecting the bile ducts and is characterized by biliary strictures, progressive liver parenchymal fibrosis, and an increased risk of hepatobiliary malignancies primarily cholangiocarcinoma (CCA). PSC may lead to portal hypertension, liver decompensation, and liver failure with the need for liver transplantation. Magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) are considered the imaging standard for diagnosis and follow-up in patients with PSC. Currently, there are no universally accepted reporting standards and definitions for MRI/MRCP features. Controversies exist about the definition of a high-grade stricture and there is no widely agreed approach to their management. The members of the MRI working group of the International Primary Sclerosing Cholangitis Study Group (IPSCSG) sought to define terminologies and reporting standards for describing MRI/MRCP features that would be applied to diagnosis and surveillance of disease progression, and potentially for evaluating treatment response in clinical trials. In this extensive review, the technique of MRI/MRCP and assessment of image quality for the evaluation of PSC is briefly described. The definitions and terminologies for severity and length of strictures, duct wall thickening and hyperenhancement, and liver parenchyma signal intensity changes are outlined. As CCA is an important complication of PSC, standardized reporting criteria for CCA developing in PSC are summarized. Finally, the guidelines for reporting important changes in follow-up MRI/MRCP studies are provided. KEY POINTS: • Primary sclerosing cholangitis is a chronic inflammatory disorder affecting the bile ducts, causing biliary strictures and liver fibrosis and an increased risk of cholangiocarcinoma. • This consensus document provides definitions and suggested reporting standards for MRI and MRCP features of primary sclerosing cholangitis, which will allow for a standardized approach to diagnosis, assessment of disease severity, follow-up, and detection of complications. • Standardized definitions and reporting of MRI/MRCP features of PSC will facilitate comparison between studies, promote longitudinal assessment during management, reduce inter-reader variability, and enhance the quality of care and communication between health care providers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bile Duct NeoplasmsCholangiocarcinomaCholangitis, SclerosingBile Ducts, IntrahepaticCholangiopancreatography, Magnetic ResonanceHumansMagnetic Resonance Imaging

Stichwörter der Autor:innen

Biliary stricturesCholangiocarcinomaDefinitionSclerosing cholangitisTerminology

Autor:innen und Institutionen

  • Division of Abdominal Imaging, Department of Radiology, Mayo Clinic, 200, First Street SW, Rochester, MN, 55905, USA. Venkatesh.sudhakar@mayo.edu.
  • Division of Abdominal Imaging, Department of Radiology, Mayo Clinic, 200, First Street SW, Rochester, MN, 55905, USA.
  • Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Joint Department of Medical Imaging, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Department of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.
  • Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.

Zitieren

APA

Venkatesh, S. K., Welle, C. L., Miller, F. H., Jhaveri, K., Ringe, K. I., Eaton, J. E., Bungay, H., Arrivé, L., Ba-Ssalamah, A., Grigoriadis, A., Schramm, C., Fulcher, A. S., & IPSCSG (2022). Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group. European Radiology, 32(2), 923-937. https://doi.org/10.1007/s00330-021-08147-7

Vancouver

Venkatesh SK, Welle CL, Miller FH, Jhaveri K, Ringe KI, Eaton JE, et al. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group. European Radiology. 2022;32(2):923-937. doi:10.1007/s00330-021-08147-7

BibTeX
@article{Venkatesh2022,
  author = {Venkatesh, Sudhakar K and Welle, Christopher L and Miller, Frank H and Jhaveri, Kartik and Ringe, Kristina I and Eaton, John E and Bungay, Helen and Arrivé, Lionel and Ba-Ssalamah, Ahmed and Grigoriadis, Aristeidis and Schramm, Christoph and Fulcher, Ann S and IPSCSG, IPSCSG},
  title = {Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group},
  journal = {European Radiology},
  year = {2022},
  volume = {32},
  number = {2},
  pages = {923--937},
  doi = {10.1007/s00330-021-08147-7}
}
Kostenlos starten →